1. Home
  2. LRMR vs WNEB Comparison

LRMR vs WNEB Comparison

Compare LRMR & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

N/A

Current Price

$3.10

Market Cap

253.5M

Sector

Health Care

ML Signal

N/A

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

N/A

Current Price

$13.12

Market Cap

271.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
LRMR
WNEB
Founded
N/A
1853
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
253.5M
271.3M
IPO Year
2014
2001

Fundamental Metrics

Financial Performance
Metric
LRMR
WNEB
Price
$3.10
$13.12
Analyst Decision
Strong Buy
Hold
Analyst Count
11
3
Target Price
$14.20
★ $15.00
AVG Volume (30 Days)
★ 1.3M
29.9K
Earning Date
11-16-2026
10-27-2026
Dividend Yield
N/A
★ 2.12%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 0.74
Revenue
N/A
★ $44,000.00
Revenue This Year
N/A
$11.31
Revenue Next Year
N/A
$8.11
P/E Ratio
★ N/A
$17.85
Revenue Growth
★ N/A
N/A
52 Week Low
$1.92
$11.74
52 Week High
$6.42
$15.01

Technical Indicators

Market Signals
Indicator
LRMR
WNEB
Relative Strength Index (RSI) 58.96 34.10
Support Level $2.89 $12.90
Resistance Level $4.25 $14.19
Average True Range (ATR) 0.30 0.31
MACD 0.09 -0.07
Stochastic Oscillator 66.40 8.00

Price Performance

Historical Comparison
LRMR
WNEB

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell penetrating peptide technology platform. Its flagship product candidate, nomlabofusp, is a subcutaneously administered recombinant fusion protein designed to deliver frataxin (FXN) to the mitochondria of patients with Friedreich's ataxia (FA), a rare genetic disease characterized by insufficient production of FXN. The company also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

Share on Social Networks: